The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK and ROS-1 versus next-generation sequence (NGS) in advanced adenocarcinoma lung cancer patients.
 
Luciene Schluckebier
Research Funding - AstraZeneca; Bristol-Myers Squibb
 
Rosangela Caetano
Research Funding - AstraZeneca
 
Veronica Aran
Research Funding - AstraZeneca
 
Carlos G. M. Ferreira
Research Funding - Bristol-Myers Squibb